Real-time enrollment status for this neoplasms, plasma cell clinical trial
Current Status
Recruiting
Checked: July 17, 2026 at 10:30 AM UTC
| NCT Number | NCT06271252 |
| Recruiting Status | Recruiting |
| Condition | Neoplasms, Plasma Cell |
| Phase | PHASE1 |
| Target Enrollment | 81 participants |
| Active Locations | 1 sites in the US |
| Sponsor | OriCell Therapeutics Co., Ltd. |
| Last Updated on CT.gov | August 2, 2024 (Aug 2, 2024) |
As of July 17, 2026: Clinical trial NCT06271252 is currently recruiting participants. This phase1 study for neoplasms, plasma cell is actively seeking new participants at 1 location across the United States. The study is sponsored by OriCell Therapeutics Co., Ltd.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06271252 is actively recruiting participants as of July 17, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 1 location in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06271252 was last updated Aug 2, 2024 (August 2, 2024). HelloStudys verifies this status automatically.